Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-11-002237
Filing Date
2011-06-07
Accepted
2011-06-07 20:22:58
Documents
2
Period of Report
2011-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3732
2 POWER OF ATTORNEY dp22981_ex24.htm EX-24 7377
  Complete submission text file 0000950103-11-002237.txt   12448
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
MILLER DANIEL H (Reporting) CIK: 0000902448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35189 | Film No.: 11899791

Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals